In a report released today, Korinne Wolfmeyer from Piper Sandler reiterated a Buy rating on Perrigo Company (PRGO – Research Report), with a price target of $42.00. The company’s shares closed yesterday at $32.95.
Wolfmeyer covers the Consumer Cyclical sector, focusing on stocks such as Inter Parfums, Ulta Beauty, and e.l.f. Beauty. According to TipRanks, Wolfmeyer has an average return of 2.4% and a 53.92% success rate on recommended stocks.
Perrigo Company has an analyst consensus of Moderate Buy, with a price target consensus of $45.50.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $39.61 and a one-year low of $26.57. Currently, Perrigo Company has an average volume of 1.78M.
Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRGO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Perrigo Company (PRGO) Company Description:
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Read More on PRGO:
